ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

10,362Medicare Part D Prescriptions Filled, Including Refills
$465K Total Retail Price of All Prescriptions
898 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
CARVEDILOL 870 572
METOPROLOL SUCCINATE 623 550
SIMVASTATIN 559 436
CLOPIDOGREL 513 387
NITROGLYCERIN PATCH 488 406 10
LISINOPRIL 481 355
FUROSEMIDE 463 323
PLAVIX 416 314
AMLODIPINE BESYLATE 396 331
WARFARIN SODIUM 338 282
METOPROLOL TARTRATE 336 271
DIGOXIN 263 253
SPIRONOLACTONE 246 166
LOSARTAN POTASSIUM 234 187
HYDRALAZINE HCL 209 139
ATORVASTATIN CALCIUM 187 152
ISOSORBIDE MONONITRATE ER 187 101
POTASSIUM CHLORIDE 153 118
PRAVASTATIN SODIUM 128 100
ATENOLOL 127 126
RANEXA 124 76
SOTALOL 120 118
PROPAFENONE HCL 106 92
NITROSTAT 102 80
RAMIPRIL 93 58
TRILIPIX 89 85
TORSEMIDE 88 44
CRESTOR 86 66
DILTIAZEM 24HR ER 80 64
COUMADIN 70 70
PRADAXA 69 69
BENAZEPRIL HCL 69 51
ENALAPRIL MALEATE 66 65
OMEPRAZOLE 65 37
VERAPAMIL ER 59 59
HYDROCHLOROTHIAZIDE 55 53
EFFIENT 55 49
LABETALOL HCL 54 35
DILTIAZEM 24HR CD 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.